Free Trial

Rocket Lab (NASDAQ:RKLB) Stock Price Down 7.8% - What's Next?

Rocket Lab logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Rocket Lab shares fell 7.8% to $59.18, extending pressure on the stock amid broader space-sector weakness, SpaceX competition, elevated valuation, ongoing losses and concerns about potential Neutron delays.
  • The company has long-term growth catalysts, including plans for 12 HASTE hypersonic tests in 2026, more than 100 missions booked and the development of its larger reusable Neutron rocket. However, investors are closely watching whether Neutron launches on schedule.
  • Analysts remain broadly optimistic, with a consensus “Moderate Buy” rating and a $104.71 price target, but insider selling—including an approximately $9.9 million sale by the CFO—has added to investor caution.
  • Five stocks we like better than Rocket Lab.

Shares of Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) fell 7.8% during trading on Wednesday. The company traded as low as $58.84 and last traded at $59.18. 20,930,075 shares were traded during mid-day trading, a decline of 9% from the average daily volume of 22,946,189 shares. The stock had previously closed at $64.22.

Rocket Lab News Roundup

Here are the key news stories impacting Rocket Lab this week:

  • Positive Sentiment: Rocket Lab reportedly plans 12 HASTE hypersonic tests in 2026, supporting U.S. weapons-development and missile-defense programs. The company describes HASTE as enabling low-cost, high-frequency testing, which could strengthen its defense business. Rocket Lab Plans 12 Hypersonic Tests in 2026 to Support U.S. Weapon Development
  • Positive Sentiment: Analyst commentary remains constructive on Rocket Lab’s long-term opportunity, citing growing satellite-launch demand, a rising launch cadence, more than 100 missions booked, and potential for the company to develop into a broader space prime. Some Wall Street estimates imply substantial upside from recent levels. SpaceX vs. RKLB: Why Wall Street Favors Rocket Lab with 62% Upside
  • Neutral Sentiment: Rocket Lab’s Electron program is approaching its 100th launch, with several upcoming missions, but investors remain focused on whether the larger, partially reusable Neutron rocket launches on schedule. Neutron is viewed as the company’s key growth and valuation catalyst. Time to Sit Tight, Says Top Investor About Rocket Lab Stock
  • Negative Sentiment: Rocket Lab’s chief financial officer reportedly sold approximately $9.9 million of stock. Although insider sales do not necessarily indicate deteriorating fundamentals, the transaction adds to investor concerns after the shares fell sharply from their May record high. Rocket Lab CFO Dumps $9.9 Million in Stock
  • Negative Sentiment: Space-sector weakness and elevated competition from SpaceX are weighing on sentiment. Piper Sandler’s concerns about SpaceX’s direct-to-cell and broader space capabilities pressured related stocks, including RKLB. Goldman Sachs also reportedly maintained a Hold rating. Rocket Lab’s high valuation, negative earnings, and potential Neutron delays leave the stock particularly sensitive to execution setbacks. AST SpaceMobile Falls as Piper Sandler Cuts Target on SpaceX Competition; Rocket Lab Slips

Wall Street Analysts Forecast Growth

RKLB has been the topic of several analyst reports. Bank of America reduced their price target on shares of Rocket Lab from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Monday, August 31st. Craig Hallum boosted their price objective on shares of Rocket Lab from $98.00 to $120.00 and gave the company a "buy" rating in a research report on Monday, June 29th. Roth Capital set a $110.00 target price on Rocket Lab in a research note on Tuesday, August 11th. Piper Sandler began coverage on Rocket Lab in a report on Wednesday, July 15th. They issued a "neutral" rating and a $83.00 target price on the stock. Finally, Citigroup started coverage on Rocket Lab in a research note on Thursday, October 1st. They issued a "buy" rating and a $105.00 price target on the stock. Four analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $104.71.

View Our Latest Research Report on RKLB

Rocket Lab Stock Down 7.8%

The firm's fifty day moving average is $70.22 and its 200-day moving average is $84.38. The company has a market capitalization of $35.41 billion, a P/E ratio of -219.18 and a beta of 2.93. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last issued its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The company had revenue of $234.07 million during the quarter, compared to analyst estimates of $231.62 million. As a group, equities research analysts predict that Rocket Lab Corporation will post -0.20 EPS for the current year.

Insider Activity

In related news, SVP Arjun Kampani sold 7,754 shares of the business's stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $539,911.02. Following the sale, the senior vice president owned 256,951 shares of the company's stock, valued at $17,891,498.13. The trade was a 2.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marvin Clevenger sold 15,051 shares of the stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $1,048,001.13. Following the completion of the sale, the insider owned 458,924 shares of the company's stock, valued at $31,954,878.12. The trade was a 3.18% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 400,749 shares of company stock valued at $26,964,474. 8.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Rocket Lab

Institutional investors have recently made changes to their positions in the stock. Reflection Asset Management bought a new stake in Rocket Lab during the 4th quarter worth approximately $30,000. Meeder Asset Management Inc. purchased a new position in Rocket Lab during the second quarter worth about $30,000. Highland Investment Advisors LLC bought a new stake in Rocket Lab in the 2nd quarter worth about $30,000. NBH Bank bought a new position in shares of Rocket Lab during the 2nd quarter worth approximately $30,000. Finally, Cherry Tree Wealth Management LLC purchased a new stake in shares of Rocket Lab during the second quarter valued at approximately $32,000. Institutional investors own 71.78% of the company's stock.

Rocket Lab Company Profile

(Get Free Report)

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab's primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Rocket Lab Right Now?

Before you consider Rocket Lab, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.

While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines